The European Stroke Organisation (ESO) guidelines on Moyamoya Angiopathy (MMA),
developed according to ESO standard operating procedure and Grading of …

Moyamoya disease (MMD) and moyamoya syndrome (MMS) are progressive vascular
pathologies unique to the cerebrovasculature that are important causes of stroke in both …

Objective: RNF213 was recently reported as a susceptibility gene for moyamoya disease
(MMD). Our aim was to clarify the correlation between the RNF213 genotype and MMD …

Objective Precise genetic analyses were conducted with ring finger protein 213 (RNF213) in
relation to a particular clinical phenotype in Chinese patients with moyamoya disease …

OBJECT Moyamoya disease (MMD) is an idiopathic cerebrovascular occlusive disorder
prevalent in East Asia. In the pathogenesis of MMD, the important role of genetic factors is …

About 5 decades have passed since the concept of moyamoya disease (MMD) was
established in Japan. In that time, many clinical MMD studies have been performed from …

Object There is no description of the change in the posterior cerebral artery (PCA) in the
diagnostic criteria of moyamoya disease (MMD). However, PCAs are often involved in the …

Background: Moyamoya disease (MMD) develops mostly in Asian countries including
Japan, Korea, mainland China and Taiwan. However, there are few detailed demographic …

Object In the study of pediatric moyamoya disease, information on long-term social
outcomes and risk factors for unfavorable social outcomes remains insufficient. The authors …

Objective Although revascularization surgery for patients with moyamoya disease can
effectively prevent ischemic events and thus improve the long-term clinical outcome, the …